Chemicals & Petrochemicals
Valuation | |
|---|---|
| Market Cap | 15.87 kCr |
| Price/Earnings (Trailing) | 35.83 |
| Price/Sales (Trailing) | 6.87 |
| EV/EBITDA | 22.59 |
| Price/Free Cashflow | -420.63 |
| MarketCap/EBT | 26.52 |
| Enterprise Value | 15.87 kCr |
Fundamentals | |
|---|---|
Growth & Returns | |
|---|---|
| Price Change 1W | 2.3% |
| Price Change 1M | -5.2% |
| Price Change 6M | -7.6% |
| Price Change 1Y | -13.6% |
| 3Y Cumulative Return | -6.5% |
| 5Y Cumulative Return | 4.6% |
| 7Y Cumulative Return | 9.8% |
| 10Y Cumulative Return | 23% |
| Revenue (TTM) |
| 2.31 kCr |
| Rev. Growth (Yr) | 2.1% |
| Earnings (TTM) | 442.94 Cr |
| Earnings Growth (Yr) | 7.6% |
Profitability | |
|---|---|
| Operating Margin | 26% |
| EBT Margin | 26% |
| Return on Equity | 14.85% |
| Return on Assets | 13.19% |
| Free Cashflow Yield | -0.24% |
Cash Flow & Liquidity |
|---|
| Cash Flow from Investing (TTM) | -442.52 Cr |
| Cash Flow from Operations (TTM) | 458.22 Cr |
| Cash Flow from Financing (TTM) | -15.58 Cr |
| Cash & Equivalents | 4.16 Cr |
| Free Cash Flow (TTM) | -42.05 Cr |
| Free Cash Flow/Share (TTM) | -4.06 |
Balance Sheet | |
|---|---|
| Total Assets | 3.3 kCr |
| Total Liabilities | 369.88 Cr |
| Shareholder Equity | 2.93 kCr |
| Current Assets | 1.01 kCr |
| Current Liabilities | 192.3 Cr |
| Net PPE | 1.73 kCr |
| Inventory | 290.1 Cr |
| Goodwill | 0.00 |
Capital Structure & Leverage | |
|---|---|
| Debt Ratio | 0.00 |
| Debt/Equity | 0.00 |
| Interest Coverage | 933.81 |
| Interest/Cashflow Ops | 665.09 |
Dividend & Shareholder Returns | |
|---|---|
| Dividend/Share (TTM) | 7.5 |
| Dividend Yield | 0.49% |
| Shares Dilution (1Y) | 0.00% |
| Shares Dilution (3Y) | 0.90% |
Technicals: Bullish SharesGuru indicator.
Smart Money: Smart money is taking extra interest in the stock as they increase their holdings.
Balance Sheet: Strong Balance Sheet.
Buy Backs: Company has bought back it's stock in the past which is a good thing.
Size: Market Cap wise it is among the top 20% companies of india.
Profitability: Very strong Profitability. One year profit margin are 19%.
Past Returns: Underperforming stock! In past three years, the stock has provided -6.5% return compared to 12.8% by NIFTY 50.
Technicals: Bullish SharesGuru indicator.
Smart Money: Smart money is taking extra interest in the stock as they increase their holdings.
Balance Sheet: Strong Balance Sheet.
Buy Backs: Company has bought back it's stock in the past which is a good thing.
Size: Market Cap wise it is among the top 20% companies of india.
Profitability: Very strong Profitability. One year profit margin are 19%.
Past Returns: Underperforming stock! In past three years, the stock has provided -6.5% return compared to 12.8% by NIFTY 50.
Investor Care | |
|---|---|
| Dividend Yield | 0.49% |
| Dividend/Share (TTM) | 7.5 |
| Shares Dilution (1Y) | 0.00% |
| Earnings/Share (TTM) | 42.73 |
Financial Health | |
|---|---|
| Current Ratio | 5.26 |
| Debt/Equity | 0.00 |
Technical Indicators | |
|---|---|
| RSI (14d) | 43.78 |
| RSI (5d) | 63.02 |
| RSI (21d) | 42.17 |
| MACD Signal | Buy |
| Stochastic Oscillator Signal | Hold |
| SharesGuru Signal | Buy |
| RSI Signal | Hold |
| RSI5 Signal | Hold |
| RSI21 Signal | Hold |
| SMA 5 Signal | Buy |
| SMA 10 Signal |
Summary of Vinati Organics's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.
Management Outlook:
Vinati Organics anticipates 20% revenue CAGR over the next three years, driven by expanded ATBS capacity (operational from FY26), growth in antioxidants, and new specialty chemicals from subsidiary Veeral Organics (VOPL). The company expects sustained demand for high-grade ATBS (70% of production), robust performance in butylphenol/IB derivatives, and steady contributions from IBB, HPMTBE, and customized products.
Major Points:
Growth Drivers:
Capex & Investments:
Margins & Challenges:
Market Positioning:
Operational Updates:
The company maintains a zero-debt policy, emphasizing prudent capital allocation and innovation in specialty chemicals.
Understand Vinati Organics ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.
| Shareholder Name | Holding % |
|---|---|
| SUCHIR CHEMICALS PRIVATE LIMITED | 45.87% |
| VINOD SARAF FAMILY TRUST (TRUSTEE VINOD SARAF) | 13.41% |
| CANARA ROBECO MUTUAL FUND A/C CANARA ROBECO MULTI CAP FUND | 3.08% |
| ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED A/C ADITYA BIRLA SUN LIFE RETIREMENT FUND THE 50S PLAN | 2.95% |
| VINATI SARAF MUTREJA | 1.17% |
| HSBC MUTUAL FUND - HSBC SMALL CAP FUND | 1.07% |
Detailed comparison of Vinati Organics against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.
Ticker | Name | Mkt Cap | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|---|
| SRF | SRF | 86.15 kCr | 15.6 kCr | -4.80% | -1.80% | 48.41 | 5.52 | - | - |
| NAVINFLUOR | Navin Fluorine International | 32.14 kCr | 2.85 kCr |
Comprehensive comparison against sector averages
VINATIORGA metrics compared to Chemicals
| Category | VINATIORGA | Chemicals |
|---|---|---|
| PE | 36.16 | 44.71 |
| PS | 6.93 | 4.17 |
| Growth | 5.1 % | 6.2 % |
Vinati Organics Limited manufactures and sells specialty organic intermediaries and monomers in India and internationally. The company offers specialty monomers comprising 2-acrylamido 2-methylpropane sulphonic acid, sodium salt of 2-acrylamido-2-methylpropane sulphonic acid, N-tertiary butyl acrylamide, and N-tertiary octyl acrylamide. It also provides specialty aromatics, including iso butyl benzene used as a basic raw material in the pharmaceutical and perfume industries; normal butyl benzene that is used in the production of N-aryl azoles; secondary butyl benzene and 3-phenylpentane that are used in perfumery and flavor industries; tertiary amyl benzene, which is used as an ingredient of electrolytes in batteries; C10 aromatic solvent used in the paints and coatings, agrochemicals, and printing inks; and 4-Butylaniline used in the water treatment chemical in corrosion inhibition. In addition, the company offers ortho tertiary butyl phenol use to produce perfumery products; ortho sec butyl phenol; para tertiary butyl phenol used in the production of epoxy, polycarbonate resins, and curing agents; and 2,4-Di tertiary butyl phenol and 2, 6-Di tertiary butyl phenol used to manufacture anti-oxidants. Further, it provides other specialty products, which includes isohexane; methyl-4-tertiary butyl benzoate; para tertiary butyl benzoic acid; isobutylene; methanol; high purity-methyl tertiary butyl ether; tertiary-butylamine; and mixed hexene. Additionally, the company offers miscellaneous polymers, including vintreat polymer, VINPLAST 245, VINFLOW HT, and vintreat-PA; Potassium Bicarbonate; and antioxidants. Vinati Organics Limited was incorporated in 1989 and is headquartered in Mumbai, India.
This is an informational page just to provide a quick 'first look' at the stock. You must do your own deeper research. Know your risk appetite. Consult a SEBI-registered financial advisor before making any investment decisions.
| Buy |
| SMA 20 Signal | Sell |
| SMA 50 Signal | Sell |
| SMA 100 Signal | Sell |
VINATIORGA vs Chemicals (2021 - 2026)
1. What were the key financial highlights for Q1 FY25?
Vinati Organics reported a 19% YoY growth in net income (Rs.533.98 crores), a 23% rise in EBIT (Rs.114.8 crores), and a 24% increase in PAT (Rs.86 crores). The growth was attributed to strong performance in ATBS, butylphenol derivatives, and antioxidants, alongside strategic capex investments.
2. What updates were provided on new product development and capex?
The company is expanding its ATBS capacity (operational from FY26) and investing over Rs.500 crores in Veeral Organics (VOPL), a subsidiary focused on MEHQ, Guaiacol, anisole, and Iso Amylene derivatives. New antioxidant products are under R&D. FY25 capex is estimated at Rs.570 crores, covering ATBS expansion and VOPL projects.
3. How did management address margin concerns for Q1?
Margins dipped sequentially due to higher raw material costs, logistics delays, and lower high-margin customized product sales in Q1. Normalization is expected from Q2/Q3, with sustained EBITDA margins projected at 26"“27% annually.
4. What is the outlook for the antioxidant business?
Antioxidant sales grew despite global demand weakness, with FY24 revenue at Rs.130 crores. Utilization is expected to reach ~50% in FY25. New antioxidants are under development, with commercialization updates to follow.
5. How is the demand environment for ATBS?
ATBS demand exceeds supply, driven by high-grade product requirements. Domestic demand is rising as customers localize polymer production. The expanded ATBS capacity (FY26) will support growth, with 70% of current volumes being high-grade.
6. What are the growth expectations and guidance?
Management reaffirmed a 20% revenue CAGR over three years, driven by ATBS, antioxidants, and VOPL products. FY25 growth remains on track despite Q1 softness, with improved performance anticipated in subsequent quarters.
7. What updates were shared on MEHQ and VOPL projects?
MEHQ sampling and plant optimization are ongoing, with meaningful revenue contributions expected from FY26. Anisole and other derivatives will cater to domestic and export markets, with initial sales focused on traders and self-consumption.
8. How are logistics and trade challenges impacting operations?
Logistics delays and higher freight costs persist, but these are largely passed to customers. Container availability issues are manageable with cost adjustments, though lead times remain extended.
9. What is the product-wise revenue breakdown for Q1?
ATBS contributed 33%, butylphenol/IB derivatives 21%, IBB 15%, IB & HPMTBE 12%, antioxidants 8%, and customized products 4%.
10. What is the status of the IBB segment?
IBB demand remains steady but lacks significant growth due to subdued API industry trends. The segment is expected to maintain stable performance in the near term.
| VIRAL SARAF MITTAL | 1.01% |
| VIRAL ALKALIS LIMITED | 0.44% |
| VINOD SARAF | 0.41% |
| KAVITA SARAF | 0% |
Distribution across major stakeholders
Distribution across major institutional holders
| +9.10% |
| +47.50% |
| 70.72 |
| 11.29 |
| - |
| - |
| ATUL | Atul | 18.41 kCr | 6.22 kCr | +1.20% | +0.80% | 30.98 | 2.96 | - | - |
| VINYLINDIA | Vinyl Chemicals (India) | 395.92 Cr | 653.51 Cr | -8.80% | -27.00% | 20.7 | 0.61 | - | - |
| 404 |
| 409 |
| 408 |
| 491 |
| 402 |
| 442 |
| Profit Before exceptional items and Tax | -13.5% | 136 | 157 | 141 | 164 | 127 | 134 |
| Total profit before tax | -13.5% | 136 | 157 | 141 | 164 | 127 | 134 |
| Current tax | -32.5% | 28 | 41 | 36 | 33 | 29 | 25 |
| Deferred tax | 1288.1% | 6.83 | 1.42 | 1.28 | 7.39 | 4.22 | 4.53 |
| Total tax | -17.1% | 35 | 42 | 37 | 41 | 33 | 29 |
| Total profit (loss) for period | -12.3% | 101 | 115 | 104 | 123 | 94 | 104 |
| Other comp. income net of taxes | -23.4% | -0.37 | -0.11 | -0.08 | 0.05 | -0.12 | -0.12 |
| Total Comprehensive Income | -13.2% | 100 | 115 | 104 | 123 | 94 | 104 |
| Earnings Per Share, Basic | -13.4% | 9.73 | 11.08 | 10.05 | 11.87 | 9.04 | 10.06 |
| Earnings Per Share, Diluted | -13.4% | 9.73 | 11.08 | 10.05 | 11.87 | 9.04 | 10.06 |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| Cost of Materials | 17% | 1,182 | 1,010 | 1,089 | 855 | 416 | 432 |
| Cost of Materials | - | - | - | - | - | - | - |
| Purchases of stock-in-trade | - | 0 | 0 | 0 | 5.81 | 0 | 0 |
| Employee Expense | 16.1% | 138 | 119 | 93 | 84 | 73 | 64 |
| Employee Expense | - | - | - | - | - | - | - |
| Finance costs | -118.3% | 0.52 | 3.63 | 0.63 | 0.26 | 0.21 | 1.09 |
| Finance costs | - | - | - | - | - | - | - |
| Depreciation and Amortization | 11.1% | 81 | 73 | 52 | 45 | 43 | 33 |
| Depreciation and Amortization | - | - | - | - | - | - | - |
| Other expenses | 9.7% | 329 | 300 | 313 | 237 | 141 | 122 |
| Other expenses | - | - | - | - | - | - | - |
| Total Expenses | 15.8% | 1,744 | 1,506 | 1,542 | 1,227 | 645 | 649 |
| Total Expenses | - | - | - | - | - | - | - |
| Profit Before exceptional items and Tax | 26.9% | 548 | 432 | 615 | 449 | 335 | 425 |
| Profit Before exceptional items and Tax | - | - | - | - | - | - | - |
| Total profit before tax | 26.9% | 548 | 432 | 615 | 449 | 335 | 425 |
| Total profit before tax | - | - | - | - | - | - | - |
| Current tax | 30.6% | 112 | 86 | 145 | 91 | 58 | 105 |
| Current tax | - | - | - | - | - | - | - |
| Deferred tax | -13% | 21 | 24 | 12 | 12 | 7.44 | -14.09 |
| Deferred tax | - | - | - | - | - | - | - |
| Total tax | 22.2% | 133 | 109 | 157 | 103 | 66 | 91 |
| Total tax | - | - | - | - | - | - | - |
| Total profit (loss) for period | 28.6% | 415 | 323 | 458 | 347 | 269 | 334 |
| Total profit (loss) for period | - | - | - | - | - | - | - |
| Other comp. income net of taxes | 13.1% | -0.33 | -0.53 | -0.51 | -0.28 | -0.19 | -0.38 |
| Other comp. income net of taxes | - | - | - | - | - | - | - |
| Total Comprehensive Income | 28.6% | 415 | 323 | 457 | 346 | 269 | 333 |
| Total Comprehensive Income | - | - | - | - | - | - | - |
| Earnings Per Share, Basic | 29.3% | 40.05 | 31.2 | 44.56 | 33.73 | 26.2 | 32.48 |
| Earnings Per Share, Basic | - | - | - | - | - | - | - |
| Earnings Per Share, Diluted | 29.3% | 40.05 | 31.2 | 44.56 | 33.73 | 26.2 | 32.48 |
| Earnings Per Share, Diluted | - | - | - | - | - | - | - |
| -2.9% |
| 1,341 |
| 1,381 |
| 1,357 |
| 1,329 |
| 1,049 |
| 881 |
| Capital work-in-progress | 24.9% | 372 | 298 | 241 | 246 | 115 | 221 |
| Investment property | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-current investments | 27.5% | 654 | 513 | 385 | 212 | 105 | 62 |
| Loans, non-current | - | 0 | 0 | 0 | 0 | 350 | 329 |
| Total non-current financial assets | 16.6% | 670 | 575 | 418 | 242 | 464 | 392 |
| Total non-current assets | 5% | 2,408 | 2,294 | 2,065 | 1,858 | 1,718 | 1,558 |
| Total assets | 1.7% | 3,320 | 3,263 | 3,022 | 2,827 | 2,643 | 2,547 |
| Total non-current financial liabilities | 9.1% | 7.59 | 7.04 | 7.76 | 6.79 | 6.63 | 6.71 |
| Total non-current liabilities | 4.4% | 168 | 161 | 161 | 157 | 150 | 109 |
| Borrowings, current | -101.6% | 0 | 63 | 7.67 | 4.65 | 0.21 | 0.2 |
| Total current financial liabilities | -54.9% | 102 | 225 | 178 | 118 | 113 | 126 |
| Provisions, current | 9.2% | 10 | 9.24 | 8.03 | 7.75 | 6.42 | 5.06 |
| Current tax liabilities | - | 9.94 | 0 | 16 | 9.26 | 12 | 9.54 |
| Total current liabilities | -38.4% | 182 | 295 | 277 | 205 | 178 | 220 |
| Total liabilities | -23.3% | 350 | 456 | 438 | 362 | 329 | 328 |
| Equity share capital | 0% | 10 | 10 | 10 | 10 | 10 | 10 |
| Total equity | 5.8% | 2,971 | 2,807 | 2,584 | 2,464 | 2,314 | 2,219 |
| Total equity and liabilities | 1.7% | 3,320 | 3,263 | 3,022 | 2,827 | 2,643 | 2,547 |
| 38.7% |
| 589 |
| 425 |
| 709 |
| 235 |
| - |
| - |
| Income taxes paid (refund) | 8.1% | 94 | 87 | 131 | 108 | - | - |
| Net Cashflows From Operating Activities | 46.3% | 494 | 338 | 578 | 127 | - | - |
| Cashflows used in obtaining control of subsidiaries | 101.7% | 348 | 173 | 20 | 8.51 | - | - |
| Proceeds from sales of PPE | 2081.8% | 3.18 | 0.89 | 0.03 | 0.23 | - | - |
| Purchase of property, plant and equipment | -17.5% | 190 | 230 | 263 | 167 | - | - |
| Dividends received | -25% | 0.05 | 0.24 | 0.37 | 0.31 | - | - |
| Interest received | 78.1% | 15 | 8.86 | 3.55 | 3.01 | - | - |
| Other inflows (outflows) of cash | 239.9% | 9.94 | -5.39 | -1.73 | 0.53 | - | - |
| Net Cashflows From Investing Activities | -35.6% | -479.74 | -353.4 | -371.56 | -255.82 | - | - |
| Proceeds from borrowings | - | 58 | 0 | 0 | 16 | - | - |
| Repayments of borrowings | -103.3% | 0 | 31 | 18 | 0 | - | - |
| Dividends paid | 0% | 72 | 72 | 67 | 62 | - | - |
| Interest paid | -118.3% | 0.52 | 3.63 | 0.63 | 0.26 | - | - |
| Other inflows (outflows) of cash | -3.2% | 0.04 | 0.07 | 0.26 | -0.76 | - | - |
| Net Cashflows from Financing Activities | 85.2% | -14.94 | -106.39 | -85.58 | -46.43 | - | - |
| Net change in cash and cash eq. | 99% | -0.24 | -121.62 | 121 | -175.15 | - | - |